D-0667-2017 Class III Terminated
FDA drug recall D-0667-2017 was initiated by Allergan Sales, LLC on Mar 16, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated May 1, 2019). Affected quantity: 56,878 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 19, 2017
- Initiation Date
- Mar 16, 2017
- Termination Date
- May 1, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 56,878 bottles
Product description
Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08.
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Nationwide in the US
Code information
Lot #: 92577, Exp. JUN 2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0667-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026